ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,587.00
3.50 (0.22%)
Last Updated: 14:42:57
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.50 0.22% 1,587.00 1,586.50 1,587.50 1,588.50 1,575.00 1,579.50 1,156,028 14:42:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.24 65.23B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,583.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £65.23 billion. Gsk has a price to earnings ratio (PE ratio) of 13.24.

Gsk Share Discussion Threads

Showing 22401 to 22422 of 33100 messages
Chat Pages: Latest  904  903  902  901  900  899  898  897  896  895  894  893  Older
DateSubjectAuthorDiscuss
19/10/2020
15:40
I've been adding today, the S/P will only get better, plus the Divi not bad either.
igoe104
18/10/2020
20:18
I was a couple of hours early with my investment on Thursday, but pleased with the rebound on Friday. With the Pfizer news, pharma stocks should see sharp rises in the coming weeks.
shammytime
18/10/2020
11:07
Lol, that's why your never hear of a rich chartist.
montyhedge
16/10/2020
21:47
Double head n shoulder no dandruff
williamcooper104
16/10/2020
21:31
Old Chinese ploverb say : Man with 2 legs walk faster than man with one....Hard to argue. spud
spud
16/10/2020
20:42
Tea leaves say.............
badtime
16/10/2020
19:50
Chart says 1300.
djb3
16/10/2020
18:02
jade - historical reasons if I may ask? My bearish positions were slightly larger at one time. ;))
alphorn
16/10/2020
17:17
And imo .. will go to 1500 ! Then make a decision
amaretto1
16/10/2020
17:15
It played the chart spot on to 13.75It should carry on riseing from here.
amaretto1
16/10/2020
17:02
GSK is if anything negatively correlated to the Great British Peso Will have a higher GBP cost base which will be less relative to its much larger USD and EUR revenue streams There's a lot of US life science interest in the U.K. which is based on our scientists being cheaper in USD terms and likely to get cheaper
williamcooper104
16/10/2020
16:57
Glaxo is U.K. listed and headquartered - but that's it - not a domestic company
williamcooper104
16/10/2020
16:55
Inflation resilient assets and a good accountant
williamcooper104
16/10/2020
16:39
Porsche, lol, his got a skateboard.
montyhedge
16/10/2020
16:27
Spent it all attempting to keep his ropey Porsche 924 on the road.....spud
spud
16/10/2020
15:33
Lol he has not got one single share. His a dreamer.
montyhedge
16/10/2020
15:32
P1945, can’t understand why you own so many GSK shares ( you said you had many more than me and I own more than £0.5 million worth) and yet you always seem to berate them!
jadeticl3
16/10/2020
15:16
Does it cannibalise current treatment? (Not belittling the positive impact for patients).
alphorn
16/10/2020
15:07
In a normal market, with that rns these would have been 1550p.
montyhedge
16/10/2020
14:34
ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

-- ViiV Healthcare's Vocabria (cabotegravir injection) used in combination with Janssen Pharmaceutical Companies of Johnson & Johnson's Rekambys (rilpivirine injection) reduces treatment dosing days from 365 to 12 or 6 per year

-- Long-acting regimen is based on co-administration of cabotegravir and rilpivirine injections once-monthly or once every 2-months to treat HIV-1

-- Vocabria (cabotegravir) tablets for use as an oral lead-in therapy with Edurant (rilpivirine tablets) prior to starting the long-acting regimen also receives positive CHMP opinion

tradermichael
16/10/2020
12:09
Thanks bears for my early Xmas present yesterday. Could not believe the price.
montyhedge
16/10/2020
09:46
Unreasonably low. Might drop a bit further next week tho with boris the bozo and his negotiating skills, but feels like near the bottom. For LT investor anytime now is a good time to go in I reckon
bogman1
Chat Pages: Latest  904  903  902  901  900  899  898  897  896  895  894  893  Older

Your Recent History

Delayed Upgrade Clock